Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct;56(10):1426-32.
doi: 10.1136/gut.2007.125286. Epub 2007 Jun 12.

The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer

Carolyn A Staton  1 , Andrew S A Chetwood, Iain C Cameron, Simon S Cross, Nicola J Brown, Malcolm W R Reed
Affiliations

The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer

Carolyn A Staton et al. Gut. 2007 Oct.

Abstract

Objective: The aim of this study was to examine the relationship between tissue factor (TF), vascular endothelial growth factor (VEGF) and the onset of angiogenesis in the adenoma-carcinoma sequence (ACS), the stepwise process encompassing colorectal cancer (CRC) disease progression.

Patients and methods: 210 surgical specimens comprising the ACS were immunohistochemically stained for endothelial cells (CD31), VEGF and TF. Angiogenesis quantified using Chalkley grid analysis (microvascular density; MVD), and VEGF/TF expression were semiquantitatively graded and correlated with standard prognostic indicators including 5 year follow-up. VEGF and TF were measured by ELISA in tumour specimens and normal mucosa from an additional 90 CRC patients.

Results: There was a significant increase in MVD across the ACS (p < 0.0005) with significant correlations with Dukes' stage (p = 0.01) and lymph node involvement (p = 0.02). The greatest increase in MVD was related to the onset of dysplasia, with an associated significant increase in VEGF expression (p < 0.0005). There was a significant relationship between VEGF and TF expression in the initial phase of the ACS (k = 0.44, p < 0.005), although no correlation between VEGF or TF, and MVD, tumour size, Dukes' classification, lymph node involvement or survival was found.

Conclusions: These findings are the first to suggest that the angiogenic switch occurs at the onset of dysplasia in the ACS, and provide further evidence of the close association between VEGF and TF in the early stages of CRC development.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Dvorak H F. Thrombosis and Cancer. Human Pathol 198718275–284. - PubMed
    1. Kakkar A K, DeRuvo N, Chinswangwatanakul V.et al Extrinsic‐pathway activation in cancer with high factor VIIa and tissue factor. Lancet 19953461004–1005. - PubMed
    1. Camerer E, Kolsto A B, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996811–41. - PubMed
    1. Nagy J A, Brown L F, Senger D R.et al Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1989948305–326. - PubMed
    1. Contrino J, Hair G, Kreutzer D L.et al In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 19962209–215. - PubMed

Publication types

MeSH terms